ARTICLES LIST

 

Total Results: 16203

Media ID Source Name Media Type Language Media Name Media Description Keywords Keywords Link to Article
567 Centers for Disease Control and Prevention Html en Use of Japanese Encephalitis Vaccine in Children:Recommendations of the Advisory Committee on ImmunizationPractices, 2013 Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov.
travel-associated JE0.541975
japanese encephalitis vaccines0.501546
je vaccine0.99336
United States0.489732
endemic areas0.504423
culture-derived Japanese encephalitis0.481797
seroprotective JE virus0.588092
JE-VC0.609822
well-defined JE virus0.570164
U.S. travelers0.480126
unsolicited adverse events0.477669
Immunization Practices0.494231
Advisory Committee0.49441
je-vc immunogenicity0.496485
JE-VC Safety Data0.48677
neurologic adverse events0.482451
children0.616038
hypersensitivity adverse events0.480478
encephalitis virus vaccines0.476766
potential JE virus0.589732
JE Epidemiology0.564671
JE Vaccine Recommendations0.608529
ACIP member roster0.474731
pneumococcal conjugate vaccine0.498331
nonendemic countries0.495086
JE disease0.542209
injection site tenderness0.506772
JE virus0.870628
recurrent travelers0.50645
ACIP Japanese Encephalitis0.490063
Japanese encephalitis vaccine0.531079
ongoing JE outbreak0.551041
adverse events0.678085
virus transmission season0.589156
urban areas0.519563
ACIP JE Vaccine0.674989
JE virus transmission0.8112
travelers0.620147
short-term travelers0.533908
dose0.504828
active JE virus0.603814
booster dose0.478141
primary series0.629208
JE-endemic countries0.516222
risk0.484624
JE virus exposure0.624462
japanese encephalitis0.589947
CLICK HERE
4637 Centers for Disease Control and Prevention Html en CDC Features: Workplace Safety & Health | CDC Features Topic-based listing of CDC Features. Workplace Safety & Health
MPEG0.276361
PDF0.201634
PPT0.326381
email address0.716575
DOC0.270026
different file formats0.90859
CLICK HERE
6035 Centers for Disease Control and Prevention Html en p-Anisidine - NIOSH Pocket Guide to Chemical Hazards null
MPEG0.378858
search0.263099
PDF0.261307
PPT0.446092
DOC0.368812
information0.262482
different file formats0.938484
page0.276773
CLICK HERE
7339 Centers for Disease Control and Prevention Html en Situation Summary on Influenza A (H3N2) Variant Viruses ("H3N2v") | Swine/Variant Influenza (Flu) Situation Summary on Influenza A (H3N2) Variant Viruses (“H3N2v”) - CDC
variant influenza viruses0.851548
swine industry0.201646
United States0.329139
case count tables0.293405
Swine influenza0.311935
H3N2v cases0.21339
case count0.33386
H1N1 pandemic virus0.424557
infected pigs0.220657
H1N2v viruses0.328404
West Virginia0.350415
pigs0.241963
Swine flu viruses0.527342
H3N2v infection0.69321
variant viruses0.663121
health care workers0.293769
U.S. pigs0.216508
sporadic infections0.396776
cases0.232966
H3N2 variant viruses0.593746
seasonal influenza0.253319
seasonal flu0.265957
variant viruses.0.219628
people0.566052
Detected U.S. Human0.395091
infected pig coughs0.323534
certain chronic conditions0.260649
human infections0.74956
influenza viruses0.957201
high risk0.369836
localized outbreaks0.335762
Limited human-to-human spread0.303483
Limited serologic studies0.276613
CLICK HERE
8716 Centers for Disease Control and Prevention Html en Emergency Preparedness for Older Adults - About null
MPEG0.378858
search0.263099
PDF0.261307
PPT0.446092
DOC0.368812
information0.262482
different file formats0.938484
page0.276773
CLICK HERE
9567 Centers for Disease Control and Prevention Html en Estimated Percentages and Characteristics of Men Who HaveSex with Men and Use Injection Drugs - United States,1999-2011 Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov.
male IDU0.667599
risk reduction programs0.424885
HIV surveillance systems0.398789
new HIV infections0.398688
IDU participants0.32493
data0.516559
data source0.309781
injection drug0.908774
intensified HIV prevention0.330618
male-to-male sexual contact0.339452
CDC. Estimated HIV0.335732
transmission category0.449564
NHBS IDU cycle0.497362
HIV infections0.431176
HIV risk behavior0.336747
sexual contact0.402107
NHSS data0.317772
adult males0.30448
IDU0.748105
HIV risk behaviors0.338961
Nutrition Examination Survey0.316127
HIV positive men0.352533
general male population0.304688
males0.369039
HIV medical care0.36586
IDU cycle eligibility0.382021
NHBS MSM cycle0.411891
human immunodeficiency virus0.319459
IDU cycle*0.329205
HIV case reporting0.350374
Medical Monitoring Project0.363101
male IDU populations0.489466
general household population0.314723
United States0.377686
MSM/IDU0.634716
high-risk IDU0.332646
National HIV Surveillance0.420948
men0.654015
surveillance systems0.452665
table0.317938
HIV Behavioral Surveillance0.421987
drugs0.327086
MSM0.623877
male-to-male sex0.577901
national surveillance systems0.321939
National HIV Behavioral0.422563
medical care0.395732
injection drug users0.527469
HIV infection0.759755
CLICK HERE
10401 Centers for Disease Control and Prevention Html en Communication Guide for Policy and Environmental Change'State Resources'DHDSP'CDC null
Environmental Change0.655697
Stroke Prevention0.807152
Disease Control0.607581
disabling0.201683
Communication Guide0.952608
heart disease0.990318
new tool0.668967
Stroke Addendum0.930965
Stroke–free States0.662722
CLICK HERE
11525 Centers for Disease Control and Prevention Html en NCIRD | DBD Bulletin Summer 2012 | Featured Publications Division of Bacterial Diseases Bulletin Summer 2012
CDC. Licensure0.56383
13-valent pneumococcal conjugate0.642931
diphtheria toxoid0.55996
Tdap vaccination program0.600518
historical purposes0.559807
pneumococcal pneumonia0.559391
PLoS One.0.556845
Trends Microbiol.0.559174
Emerg Infect Dis.0.61785
Bordetella pertussis DNA0.687809
tetanus toxoid0.559513
pneumococcal conjugate vaccine0.747369
Invasive pneumococcal disease0.608081
Bordetella pertussis0.691935
acellular pertussis0.657028
Washington State Department0.591123
conjugate pneumococcal vaccine0.668058
Clin Infect Dis.0.630611
Clark TA0.604745
current pertussis outbreak0.673161
Infect Dis.0.671561
pneumococcal polysaccharide vaccine0.635283
Gershman KA0.555044
Emerg Infect Dis0.613677
Pertussis pseudo-outbreak0.63811
meningococcal vaccine0.606163
CDC. Comparison0.56032
United States0.757255
Neisseria meningitidis serogroup0.623118
adult vaccination strategies0.596749
MacNeil JR0.554378
pathogen Haemophilus haemolyticus0.61292
Immunization Practices0.557036
Advisory Committee0.556772
Messonnier NE0.611298
meningococcal disease surveillance0.627311
Jordan IK0.554213
Pediatr Adolesc Med.0.589301
Cohn AC0.672832
pertussis infection0.632374
Pertussis epidemic0.633335
CDC. Updated recommendation0.607934
Baughman AL0.574381
Clin Vaccine Immunol.0.638272
Dunning Hotopp JC0.60017
Haemophilus influenzae disease0.619947
et al0.912993
Pertussis control0.652258
pertussis trends0.63125
CLICK HERE
13409 Centers for Disease Control and Prevention Html en Introduction of Inactivated Poliovirus Vaccine and Switchfrom Trivalent to Bivalent Oral Poliovirus Vaccine - Worldwide,2013-2016 Immunization Systems Management Group of the Global Polio Eradication Initiative.
trivalent inactivated poliovirus0.391167
global IPV supply0.404566
polioviruses0.768447
environmental surveillance0.454984
flaccid paralysis cases0.388372
supplemental immunization0.719967
oral poliovirus vaccine0.406894
polio outbreaks0.433211
low vaccination coverage0.3862
type0.656342
OPV-using countries0.386343
IPV0.59079
monovalent OPV type0.409268
switch0.924066
attenuated polioviruses0.471872
OPV polioviruses0.483492
vaccination coverage0.389767
tOPV0.721065
new cVDPV2 outbreaks0.450322
routine immunization0.992343
paralytic polio0.692615
wild polioviruses0.644037
IPV introduction dates0.408418
supplemental immunization campaigns0.590944
routine immunization efforts0.457188
routine immunization schedules0.636471
Global Polio Eradication0.599518
bOPV0.653872
Multiple supplemental immunization0.439183
supplemental immunization activities0.569433
poliovirus outbreaks0.53401
Polio Eradication Initiative0.591007
routine immunization delivery0.472459
tOPV supplemental immunization0.458977
global withdrawal0.434742
countries0.675119
WPV type0.394016
World Health Assembly0.552835
routine immunization programs0.552099
acute flaccid paralysis0.881187
global switch0.622179
vaccine-derived polioviruses0.463799
low polio vaccination0.412764
risk0.394152
Health Assembly resolution0.393206
outbreaks0.608404
supplemental immunization activities*0.45078
CLICK HERE
16317 Centers for Disease Control and Prevention Html en Nutrition and the Health of Young People | Healthy Schools null
total caloric intake.100.675745
Human Services0.651633
Human Brain Mapping.0.646746
children0.793757
Cancer Society Guidelines0.674858
Nutr J.0.658858
food insecurity0.68698
Nutrition Examination Survey0.658333
American Dietetic Association.0.790545
MS. Food Insecurity0.673589
overall health0.61193
adolescents0.664376
School health guidelines0.683918
National Academies Press0.65281
healthy eating0.733746
Fewer Liquid Calories0.688225
adolescents age0.632977
Dietary Guidelines0.828005
National Health0.602578
Constant F. Water0.653394
Dietary Sources0.625632
Cancer Journal0.602338
Dietary Guidelines Advisory0.716398
healthy eating pattern0.688193
trans fatty acids0.665736
American School-aged Children0.703649
Guidelines Advisory Committee0.784501
United States0.744916
Secretary Health0.607551
various health conditions.1,20.701033
poor diet0.661884
cognitive performance0.647257
solid fats0.776935
total fruit intake0.706318
Federal Dietary Recommendations0.690177
Healthy Food Choices0.669198
lower dietary quality0.708092
added sugars0.674698
Rehm CD0.669182
physical activity0.721041
Healthy Adolescents0.62007
Krebs-Smith SM0.658768
et al0.948729
Jeffes B. Does0.64774
Nutrition Research Reviews.0.653432
Beverage Consumption Patterns0.66063
7-year-old children0.624478
daily calories0.63682
CLICK HERE

 

 

 

Terms of Use | Privacy Policy
©2017 ARCHES Technology. All Rights Reserved.